Lanreotide Autogel-120 mg as First-Line Treatment of Acromegaly
Clinical trial NCT00627796 · COMPLETED
Trial details
- NCT number
- NCT00627796
- Sponsor
- Federico II University
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2003-01-01
- Primary completion
- 2007-12-01
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.